Index by author
April 01, 2020; Volume 373,Issue 1
A
Amagase, Kikuko
- You have accessLeukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell ProliferationYui Matsumoto, Yukiko Matsuya, Kano Nagai, Kikuko Amagase, Kazuko Saeki, Kenjiro Matsumoto, Takehiko Yokomizo and Shinichi KatoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 1-9; DOI: https://doi.org/10.1124/jpet.119.263145
Andreassen, Kim Vietz
- You have accessThe Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin ActionNina Sonne, Anna Thorsø Larsen, Kim Vietz Andreassen, Morten Asser Karsdal and Kim HenriksenJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 92-102; DOI: https://doi.org/10.1124/jpet.119.263723
B
Banerjee, Pradeep
- Open AccessCharacterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide ReceptorEric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher SalvatoreJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065
Barnes, Nicholas M.
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
Bell, Ian M.
- Open AccessCharacterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide ReceptorEric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher SalvatoreJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065
Borejdo, Julian
- You have accessProbing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic FluorescenceSangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras LackoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899
Brady, Catherine A.
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
Brock, Kristian
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
Brown, Kyle A.
- You have accessDorsoventral-Specific Effects of Nerve Agent Surrogate Diisopropylfluorophosphate on Synaptic Transmission in the Mouse HippocampusKyle A. Brown, Nikolay M. Filipov and John J. WagnerJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 10-23; DOI: https://doi.org/10.1124/jpet.119.263053
Burgey, Christopher S.
- Open AccessCharacterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide ReceptorEric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher SalvatoreJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065
C
Calo, Girolamo
- You have accessDetailed In Vitro Pharmacological Characterization of the Clinically Viable Nociceptin/Orphanin FQ Peptide Receptor Antagonist BTRX-246040Federica Ferrari, Sabrina Rizzo, Chiara Ruzza and Girolamo CaloJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 34-43; DOI: https://doi.org/10.1124/jpet.119.262865
Cantoni, Orazio
- You have accessArsenite-Induced Mitochondrial Superoxide Formation: Time and Concentration Requirements for the Effects of the Metalloid on the Endoplasmic Reticulum and MitochondriaAndrea Guidarelli, Liana Cerioni, Mara Fiorani, Alessia Catalani and Orazio CantoniJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 62-71; DOI: https://doi.org/10.1124/jpet.119.262469
Catalani, Alessia
- You have accessArsenite-Induced Mitochondrial Superoxide Formation: Time and Concentration Requirements for the Effects of the Metalloid on the Endoplasmic Reticulum and MitochondriaAndrea Guidarelli, Liana Cerioni, Mara Fiorani, Alessia Catalani and Orazio CantoniJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 62-71; DOI: https://doi.org/10.1124/jpet.119.262469
Cerioni, Liana
- You have accessArsenite-Induced Mitochondrial Superoxide Formation: Time and Concentration Requirements for the Effects of the Metalloid on the Endoplasmic Reticulum and MitochondriaAndrea Guidarelli, Liana Cerioni, Mara Fiorani, Alessia Catalani and Orazio CantoniJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 62-71; DOI: https://doi.org/10.1124/jpet.119.262469
Chen, Chunlin
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
Cooper, Alison J.
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
D
Dang, Danny
- You have accessEnhancing KCNQ Channel Activity Improves Neurobehavioral Recovery after Spinal Cord InjuryZizhen Wu, Lin Li, Fuhua Xie, Guoying Xu, Danny Dang and Qing YangJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 72-80; DOI: https://doi.org/10.1124/jpet.119.264010
Danziger, Andrew
- Open AccessCharacterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide ReceptorEric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher SalvatoreJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065
Demireva, Elena Y.
- You have accessMice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by RisperidoneCasandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie and Richard R. NeubigJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 24-33; DOI: https://doi.org/10.1124/jpet.119.262733
Dozono, Naoki
- You have accessNR2A-NMDA Receptor Blockade Reverses the Lack of Morphine Analgesia Without Affecting Chronic Pain Status in a Fibromyalgia-Like Mouse ModelHiroyuki Neyama, Naoki Dozono and Hiroshi UedaJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 103-112; DOI: https://doi.org/10.1124/jpet.119.262642
Dzyuba, Sergei V.
- You have accessProbing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic FluorescenceSangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras LackoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899
F
Fan, Jiaoyang
- Open AccessCDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor ComplexLiang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng LuJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434
Feng, Huijie
- You have accessMice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by RisperidoneCasandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie and Richard R. NeubigJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 24-33; DOI: https://doi.org/10.1124/jpet.119.262733
Ferrari, Federica
- You have accessDetailed In Vitro Pharmacological Characterization of the Clinically Viable Nociceptin/Orphanin FQ Peptide Receptor Antagonist BTRX-246040Federica Ferrari, Sabrina Rizzo, Chiara Ruzza and Girolamo CaloJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 34-43; DOI: https://doi.org/10.1124/jpet.119.262865
Filipov, Nikolay M.
- You have accessDorsoventral-Specific Effects of Nerve Agent Surrogate Diisopropylfluorophosphate on Synaptic Transmission in the Mouse HippocampusKyle A. Brown, Nikolay M. Filipov and John J. WagnerJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 10-23; DOI: https://doi.org/10.1124/jpet.119.263053
Fiorani, Mara
- You have accessArsenite-Induced Mitochondrial Superoxide Formation: Time and Concentration Requirements for the Effects of the Metalloid on the Endoplasmic Reticulum and MitochondriaAndrea Guidarelli, Liana Cerioni, Mara Fiorani, Alessia Catalani and Orazio CantoniJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 62-71; DOI: https://doi.org/10.1124/jpet.119.262469
Fraley, Mark E.
- Open AccessCharacterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide ReceptorEric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher SalvatoreJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065
Fudala, Rafal
- You have accessProbing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic FluorescenceSangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras LackoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899
G
Garud, Ashwini
- You have accessProbing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic FluorescenceSangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras LackoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899
Gillespie, Delbert G.
- Open AccessDPP4 Inhibition, NPY1-36, PYY1-36, SDF-1α, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-MethoxyestradiolEdwin K. Jackson, Delbert G. Gillespie and Stevan P. TofovicJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 135-148; DOI: https://doi.org/10.1124/jpet.119.263467
Grafton, Gillian
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
Gryczynski, Ignacy
- You have accessProbing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic FluorescenceSangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras LackoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899
Gryczynski, Zygmunt
- You have accessProbing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic FluorescenceSangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras LackoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899
Guidarelli, Andrea
- You have accessArsenite-Induced Mitochondrial Superoxide Formation: Time and Concentration Requirements for the Effects of the Metalloid on the Endoplasmic Reticulum and MitochondriaAndrea Guidarelli, Liana Cerioni, Mara Fiorani, Alessia Catalani and Orazio CantoniJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 62-71; DOI: https://doi.org/10.1124/jpet.119.262469
Guzzo, Peter R.
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
H
Henriksen, Kim
- You have accessThe Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin ActionNina Sonne, Anna Thorsø Larsen, Kim Vietz Andreassen, Morten Asser Karsdal and Kim HenriksenJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 92-102; DOI: https://doi.org/10.1124/jpet.119.263723
Hostetler, Eric
- Open AccessCharacterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide ReceptorEric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher SalvatoreJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065
Huang, Jinkun
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
J
Jackson, Edwin K.
- Open AccessDPP4 Inhibition, NPY1-36, PYY1-36, SDF-1α, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-MethoxyestradiolEdwin K. Jackson, Delbert G. Gillespie and Stevan P. TofovicJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 135-148; DOI: https://doi.org/10.1124/jpet.119.263467
Jakimczuk, Aleksandra
- Open AccessHeparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in RatsBartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej MogielnickiJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931
Jin, Xin
- You have accessOleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic ModelTong Ren, Ang Ma, Rengong Zhuo, Huaying Zhang, Lu Peng, Xin Jin, Enhui Yao and Lichao YangJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 81-91; DOI: https://doi.org/10.1124/jpet.119.262675
John, William S.
- You have accessCannabinoid Modulation of Food-Cocaine Choice in Male Rhesus MonkeysWilliam S. John, Thomas J. Martin and Michael A. NaderJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 44-50; DOI: https://doi.org/10.1124/jpet.119.263707
K
Kalaska, Bartlomiej
- Open AccessHeparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in RatsBartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej MogielnickiJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931
Kamiński, Kamil
- Open AccessHeparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in RatsBartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej MogielnickiJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931
Karsdal, Morten Asser
- You have accessThe Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin ActionNina Sonne, Anna Thorsø Larsen, Kim Vietz Andreassen, Morten Asser Karsdal and Kim HenriksenJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 92-102; DOI: https://doi.org/10.1124/jpet.119.263723
Kato, Shinichi
- You have accessLeukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell ProliferationYui Matsumoto, Yukiko Matsuya, Kano Nagai, Kikuko Amagase, Kazuko Saeki, Kenjiro Matsumoto, Takehiko Yokomizo and Shinichi KatoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 1-9; DOI: https://doi.org/10.1124/jpet.119.263145
L
Lacko, Andras
- You have accessProbing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic FluorescenceSangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras LackoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899
Larrivee, Casandra L.
- You have accessMice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by RisperidoneCasandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie and Richard R. NeubigJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 24-33; DOI: https://doi.org/10.1124/jpet.119.262733
Larsen, Anna Thorsø
- You have accessThe Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin ActionNina Sonne, Anna Thorsø Larsen, Kim Vietz Andreassen, Morten Asser Karsdal and Kim HenriksenJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 92-102; DOI: https://doi.org/10.1124/jpet.119.263723
Leipprandt, Jeffrey R.
- You have accessMice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by RisperidoneCasandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie and Richard R. NeubigJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 24-33; DOI: https://doi.org/10.1124/jpet.119.262733
Li, Chi-Chung
- Open AccessCharacterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide ReceptorEric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher SalvatoreJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065
Li, Lin
- You have accessEnhancing KCNQ Channel Activity Improves Neurobehavioral Recovery after Spinal Cord InjuryZizhen Wu, Lin Li, Fuhua Xie, Guoying Xu, Danny Dang and Qing YangJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 72-80; DOI: https://doi.org/10.1124/jpet.119.264010
Liu, Shanshan
- Open AccessCDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor ComplexLiang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng LuJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434
Liu, Shuang
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
Lu, Desheng
- Open AccessCDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor ComplexLiang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng LuJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434
Lyu, Yansi
- Open AccessCDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor ComplexLiang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng LuJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434
M
Ma, Ang
- You have accessOleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic ModelTong Ren, Ang Ma, Rengong Zhuo, Huaying Zhang, Lu Peng, Xin Jin, Enhui Yao and Lichao YangJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 81-91; DOI: https://doi.org/10.1124/jpet.119.262675
Manning, David D.
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
Martin, Thomas J.
- You have accessCannabinoid Modulation of Food-Cocaine Choice in Male Rhesus MonkeysWilliam S. John, Thomas J. Martin and Michael A. NaderJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 44-50; DOI: https://doi.org/10.1124/jpet.119.263707
Matsumoto, Kenjiro
- You have accessLeukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell ProliferationYui Matsumoto, Yukiko Matsuya, Kano Nagai, Kikuko Amagase, Kazuko Saeki, Kenjiro Matsumoto, Takehiko Yokomizo and Shinichi KatoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 1-9; DOI: https://doi.org/10.1124/jpet.119.263145
Matsumoto, Yui
- You have accessLeukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell ProliferationYui Matsumoto, Yukiko Matsuya, Kano Nagai, Kikuko Amagase, Kazuko Saeki, Kenjiro Matsumoto, Takehiko Yokomizo and Shinichi KatoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 1-9; DOI: https://doi.org/10.1124/jpet.119.263145
Matsuya, Yukiko
- You have accessLeukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell ProliferationYui Matsumoto, Yukiko Matsuya, Kano Nagai, Kikuko Amagase, Kazuko Saeki, Kenjiro Matsumoto, Takehiko Yokomizo and Shinichi KatoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 1-9; DOI: https://doi.org/10.1124/jpet.119.263145
Michener, Maria Stranieri
- Open AccessCharacterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide ReceptorEric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher SalvatoreJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065
Miklosz, Joanna
- Open AccessHeparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in RatsBartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej MogielnickiJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931
Mogielnicki, Andrzej
- Open AccessHeparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in RatsBartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej MogielnickiJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931
Moore, Eric
- Open AccessCharacterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide ReceptorEric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher SalvatoreJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065
Moore, Nicholas A.
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
N
Nader, Michael A.
- You have accessCannabinoid Modulation of Food-Cocaine Choice in Male Rhesus MonkeysWilliam S. John, Thomas J. Martin and Michael A. NaderJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 44-50; DOI: https://doi.org/10.1124/jpet.119.263707
Nagai, Kano
- You have accessLeukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell ProliferationYui Matsumoto, Yukiko Matsuya, Kano Nagai, Kikuko Amagase, Kazuko Saeki, Kenjiro Matsumoto, Takehiko Yokomizo and Shinichi KatoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 1-9; DOI: https://doi.org/10.1124/jpet.119.263145
Nagarajan, Bhavani
- You have accessProbing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic FluorescenceSangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras LackoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899
Neubig, Richard R.
- You have accessMice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by RisperidoneCasandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie and Richard R. NeubigJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 24-33; DOI: https://doi.org/10.1124/jpet.119.262733
Neyama, Hiroyuki
- You have accessNR2A-NMDA Receptor Blockade Reverses the Lack of Morphine Analgesia Without Affecting Chronic Pain Status in a Fibromyalgia-Like Mouse ModelHiroyuki Neyama, Naoki Dozono and Hiroshi UedaJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 103-112; DOI: https://doi.org/10.1124/jpet.119.262642
Nowakowska, Maria
- Open AccessHeparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in RatsBartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej MogielnickiJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931
P
Pawlak, Dariusz
- Open AccessHeparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in RatsBartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej MogielnickiJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931
Peng, Lu
- You have accessOleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic ModelTong Ren, Ang Ma, Rengong Zhuo, Huaying Zhang, Lu Peng, Xin Jin, Enhui Yao and Lichao YangJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 81-91; DOI: https://doi.org/10.1124/jpet.119.262675
Powell, Andrew D.
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
Q
Quinn, Josiah A.
- You have accessMice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by RisperidoneCasandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie and Richard R. NeubigJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 24-33; DOI: https://doi.org/10.1124/jpet.119.262733
Qureshi, Omar
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
R
Raut, Sangram
- You have accessProbing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic FluorescenceSangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras LackoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899
Regan, Christopher P.
- Open AccessCharacterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide ReceptorEric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher SalvatoreJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065
Remaley, Alan
- You have accessProbing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic FluorescenceSangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras LackoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899
Ren, Tong
- You have accessOleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic ModelTong Ren, Ang Ma, Rengong Zhuo, Huaying Zhang, Lu Peng, Xin Jin, Enhui Yao and Lichao YangJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 81-91; DOI: https://doi.org/10.1124/jpet.119.262675
Rizzo, Sabrina
- You have accessDetailed In Vitro Pharmacological Characterization of the Clinically Viable Nociceptin/Orphanin FQ Peptide Receptor Antagonist BTRX-246040Federica Ferrari, Sabrina Rizzo, Chiara Ruzza and Girolamo CaloJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 34-43; DOI: https://doi.org/10.1124/jpet.119.262865
Roberts, Alexander
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
Ruzza, Chiara
- You have accessDetailed In Vitro Pharmacological Characterization of the Clinically Viable Nociceptin/Orphanin FQ Peptide Receptor Antagonist BTRX-246040Federica Ferrari, Sabrina Rizzo, Chiara Ruzza and Girolamo CaloJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 34-43; DOI: https://doi.org/10.1124/jpet.119.262865
S
Sabnis, Nirupama
- You have accessProbing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic FluorescenceSangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras LackoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899
Saeki, Kazuko
- You have accessLeukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell ProliferationYui Matsumoto, Yukiko Matsuya, Kano Nagai, Kikuko Amagase, Kazuko Saeki, Kenjiro Matsumoto, Takehiko Yokomizo and Shinichi KatoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 1-9; DOI: https://doi.org/10.1124/jpet.119.263145
Salvatore, Christopher
- Open AccessCharacterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide ReceptorEric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher SalvatoreJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065
Sargent, Bruce J.
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
Shaw, Vincent S.
- You have accessMice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by RisperidoneCasandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie and Richard R. NeubigJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 24-33; DOI: https://doi.org/10.1124/jpet.119.262733
Song, Jiaxing
- Open AccessCDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor ComplexLiang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng LuJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434
Sonne, Nina
- You have accessThe Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin ActionNina Sonne, Anna Thorsø Larsen, Kim Vietz Andreassen, Morten Asser Karsdal and Kim HenriksenJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 92-102; DOI: https://doi.org/10.1124/jpet.119.263723
Stamataki, Zania
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
Su, Zijie
- Open AccessCDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor ComplexLiang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng LuJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434
Sun, Qi
- Open AccessCDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor ComplexLiang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng LuJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434
Swieton, Justyna
- Open AccessHeparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in RatsBartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej MogielnickiJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931
Szczubiałka, Krzysztof
- Open AccessHeparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in RatsBartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej MogielnickiJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931
T
Tofovic, Stevan P.
- Open AccessDPP4 Inhibition, NPY1-36, PYY1-36, SDF-1α, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-MethoxyestradiolEdwin K. Jackson, Delbert G. Gillespie and Stevan P. TofovicJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 135-148; DOI: https://doi.org/10.1124/jpet.119.263467
U
Ueda, Hiroshi
- You have accessNR2A-NMDA Receptor Blockade Reverses the Lack of Morphine Analgesia Without Affecting Chronic Pain Status in a Fibromyalgia-Like Mouse ModelHiroyuki Neyama, Naoki Dozono and Hiroshi UedaJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 103-112; DOI: https://doi.org/10.1124/jpet.119.262642
W
Wagner, John J.
- You have accessDorsoventral-Specific Effects of Nerve Agent Surrogate Diisopropylfluorophosphate on Synaptic Transmission in the Mouse HippocampusKyle A. Brown, Nikolay M. Filipov and John J. WagnerJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 10-23; DOI: https://doi.org/10.1124/jpet.119.263053
Wang, Zhongyuan
- Open AccessCDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor ComplexLiang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng LuJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434
White, Rebecca B.
- Open AccessCharacterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide ReceptorEric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher SalvatoreJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065
Wu, Zizhen
- You have accessEnhancing KCNQ Channel Activity Improves Neurobehavioral Recovery after Spinal Cord InjuryZizhen Wu, Lin Li, Fuhua Xie, Guoying Xu, Danny Dang and Qing YangJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 72-80; DOI: https://doi.org/10.1124/jpet.119.264010
X
Xie, Dejian
- Open AccessCSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid SyndromeAlexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. BarnesJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008
Xie, Fuhua
- You have accessEnhancing KCNQ Channel Activity Improves Neurobehavioral Recovery after Spinal Cord InjuryZizhen Wu, Lin Li, Fuhua Xie, Guoying Xu, Danny Dang and Qing YangJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 72-80; DOI: https://doi.org/10.1124/jpet.119.264010
Xie, Huirong
- You have accessMice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by RisperidoneCasandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie and Richard R. NeubigJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 24-33; DOI: https://doi.org/10.1124/jpet.119.262733
Xiong, Yanpeng
- Open AccessCDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor ComplexLiang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng LuJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434
Xu, Guoying
- You have accessEnhancing KCNQ Channel Activity Improves Neurobehavioral Recovery after Spinal Cord InjuryZizhen Wu, Lin Li, Fuhua Xie, Guoying Xu, Danny Dang and Qing YangJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 72-80; DOI: https://doi.org/10.1124/jpet.119.264010
Y
Yang, Lichao
- You have accessOleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic ModelTong Ren, Ang Ma, Rengong Zhuo, Huaying Zhang, Lu Peng, Xin Jin, Enhui Yao and Lichao YangJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 81-91; DOI: https://doi.org/10.1124/jpet.119.262675
Yang, Qing
- You have accessEnhancing KCNQ Channel Activity Improves Neurobehavioral Recovery after Spinal Cord InjuryZizhen Wu, Lin Li, Fuhua Xie, Guoying Xu, Danny Dang and Qing YangJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 72-80; DOI: https://doi.org/10.1124/jpet.119.264010
Yao, Enhui
- You have accessOleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic ModelTong Ren, Ang Ma, Rengong Zhuo, Huaying Zhang, Lu Peng, Xin Jin, Enhui Yao and Lichao YangJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 81-91; DOI: https://doi.org/10.1124/jpet.119.262675
Yokomizo, Takehiko
- You have accessLeukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell ProliferationYui Matsumoto, Yukiko Matsuya, Kano Nagai, Kikuko Amagase, Kazuko Saeki, Kenjiro Matsumoto, Takehiko Yokomizo and Shinichi KatoJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 1-9; DOI: https://doi.org/10.1124/jpet.119.263145
Yu, Shubin
- Open AccessCDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor ComplexLiang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng LuJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434
Yusa, Shin-Ichi
- Open AccessHeparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in RatsBartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej MogielnickiJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931
Z
Zhang, Huaying
- You have accessOleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic ModelTong Ren, Ang Ma, Rengong Zhuo, Huaying Zhang, Lu Peng, Xin Jin, Enhui Yao and Lichao YangJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 81-91; DOI: https://doi.org/10.1124/jpet.119.262675
Zhou, Liang
- Open AccessCDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor ComplexLiang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng LuJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434
Zhuo, Rengong
- You have accessOleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic ModelTong Ren, Ang Ma, Rengong Zhuo, Huaying Zhang, Lu Peng, Xin Jin, Enhui Yao and Lichao YangJournal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 81-91; DOI: https://doi.org/10.1124/jpet.119.262675
In this issue

Advertisement